Details
Stereochemistry | ACHIRAL |
Molecular Formula | CO3.Fe |
Molecular Weight | 115.854 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Fe++].[O-]C([O-])=O
InChI
InChIKey=RAQDACVRFCEPDA-UHFFFAOYSA-L
InChI=1S/CH2O3.Fe/c2-1(3)4;/h(H2,2,3,4);/q;+2/p-2
Molecular Formula | CO3 |
Molecular Weight | 60.0089 |
Charge | -2 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | Fe |
Molecular Weight | 55.845 |
Charge | 2 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/14116934http://www.foodchemadditives.com/products/Ferrous-Lactatehttp://nj.gov/health/eoh/rtkweb/documents/fs/0928.pdfDOI: 10.1021/ja00949a016 Retrived from http://pubs.acs.org/doi/abs/10.1021/ja00949a016https://www.drugs.com/inactive/ferrous-oxide-389.htmlhttp://www.druglead.com/cds/ferrous-iodide.htmlhttp://www.drugfuture.com/chemdata/ferroglycine-sulfate.htmlhttps://www.ncbi.nlm.nih.gov/pubmed/16694502Curator's Comment: description was created based on several sources, including
http://www.minapharm.com/Public/ProductDetails.aspx?ProductCode=FERRO_SANO&langParam=en
Sources: https://www.ncbi.nlm.nih.gov/pubmed/14116934http://www.foodchemadditives.com/products/Ferrous-Lactatehttp://nj.gov/health/eoh/rtkweb/documents/fs/0928.pdfDOI: 10.1021/ja00949a016 Retrived from http://pubs.acs.org/doi/abs/10.1021/ja00949a016https://www.drugs.com/inactive/ferrous-oxide-389.htmlhttp://www.druglead.com/cds/ferrous-iodide.htmlhttp://www.drugfuture.com/chemdata/ferroglycine-sulfate.htmlhttps://www.ncbi.nlm.nih.gov/pubmed/16694502
Curator's Comment: description was created based on several sources, including
http://www.minapharm.com/Public/ProductDetails.aspx?ProductCode=FERRO_SANO&langParam=en
Iron(II) gluconate (also known as a ferrous gluconate) is used in the treatment of hypochromic anemia. The real problem of iron therapy is not the theoretical utilization of iron, or the reticulocyte response, or even the daily increase of hemoglobin. These are important only as they indicate the return of the patients' blood to normal in a reasonably short time without undue inconvenience. Most patients suffering from hypochromic anemia respond well to most forms of iron when administered in adequate dosage. For the patients who cannot tolerate the usual iron compounds, it is important to have a medication which is effective and which causes minimum disturbance. Ferrous gluconate is such a medicament.
Originator
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Palliative | Unknown Approved UseUnknown |
|||
Palliative | Unknown Approved UseUnknown |
|||
Primary | Ferro Sanol Duodenal Approved UseFerro Sanol is an iron substitute in case of latent or manifest iron deficiency with and without development of anaemia. |
|||
PubMed
Title | Date | PubMed |
---|---|---|
THE ADMINISTRATION OF FERROUS IODIDE AND LINOLEIC ACID TO RATS DEPRIVED OF VITAMIN A. | 1932 Sep 30 |
|
[FERROUS ASPARTATE IN THERAPY]. | 1964 Jan 1 |
|
[Historical notes on the therapy of depression]. | 1986 Nov 22 |
|
Determination of water in ferrous lactate by near infrared reflectance spectroscopy with a fibre-optic probe. | 1997 Oct |
|
Reversal of multidrug resistance by magnetic Fe3O4 nanoparticle copolymerizating daunorubicin and 5-bromotetrandrine in xenograft nude-mice. | 2009 |
|
Bioleaching of heavy metals from sewage sludge by indigenous iron-oxidizing microorganisms using ammonium ferrous sulfate and ferrous sulfate as energy sources: a comparative study. | 2009 Nov 15 |
|
The effect of iron treatment on adhesion molecules in patients with iron deficiency anemia. | 2010 Dec |
|
Effect of abomasal ferrous lactate infusion on phosphorus absorption in lactating dairy cows. | 2013 Jul |
|
A practical and successful desensitization protocol for immediate hypersensitivity reactions to iron salts. | 2014 |
|
Continuous sulfidogenic wastewater treatment with iron sulfide sludge oxidation and recycle. | 2017 May 1 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.drugs.com/ppa/ferrous-salts.html
Unknown
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:55:11 GMT 2023
by
admin
on
Fri Dec 15 15:55:11 GMT 2023
|
Record UNII |
MZ3Q72U52O
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
B03AA04
Created by
admin on Fri Dec 15 15:55:11 GMT 2023 , Edited by admin on Fri Dec 15 15:55:11 GMT 2023
|
||
|
CFR |
21 CFR 184.1307B
Created by
admin on Fri Dec 15 15:55:11 GMT 2023 , Edited by admin on Fri Dec 15 15:55:11 GMT 2023
|
||
|
WHO-VATC |
QB03AA04
Created by
admin on Fri Dec 15 15:55:11 GMT 2023 , Edited by admin on Fri Dec 15 15:55:11 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
86235
Created by
admin on Fri Dec 15 15:55:11 GMT 2023 , Edited by admin on Fri Dec 15 15:55:11 GMT 2023
|
PRIMARY | |||
|
209-259-6
Created by
admin on Fri Dec 15 15:55:11 GMT 2023 , Edited by admin on Fri Dec 15 15:55:11 GMT 2023
|
PRIMARY | |||
|
C82285
Created by
admin on Fri Dec 15 15:55:11 GMT 2023 , Edited by admin on Fri Dec 15 15:55:11 GMT 2023
|
PRIMARY | |||
|
11248
Created by
admin on Fri Dec 15 15:55:11 GMT 2023 , Edited by admin on Fri Dec 15 15:55:11 GMT 2023
|
PRIMARY | |||
|
SUB13861MIG
Created by
admin on Fri Dec 15 15:55:11 GMT 2023 , Edited by admin on Fri Dec 15 15:55:11 GMT 2023
|
PRIMARY | |||
|
563-71-3
Created by
admin on Fri Dec 15 15:55:11 GMT 2023 , Edited by admin on Fri Dec 15 15:55:11 GMT 2023
|
PRIMARY | |||
|
100000078448
Created by
admin on Fri Dec 15 15:55:11 GMT 2023 , Edited by admin on Fri Dec 15 15:55:11 GMT 2023
|
PRIMARY | |||
|
MZ3Q72U52O
Created by
admin on Fri Dec 15 15:55:11 GMT 2023 , Edited by admin on Fri Dec 15 15:55:11 GMT 2023
|
PRIMARY | |||
|
MZ3Q72U52O
Created by
admin on Fri Dec 15 15:55:11 GMT 2023 , Edited by admin on Fri Dec 15 15:55:11 GMT 2023
|
PRIMARY | |||
|
C486982
Created by
admin on Fri Dec 15 15:55:11 GMT 2023 , Edited by admin on Fri Dec 15 15:55:11 GMT 2023
|
PRIMARY | |||
|
1440290
Created by
admin on Fri Dec 15 15:55:11 GMT 2023 , Edited by admin on Fri Dec 15 15:55:11 GMT 2023
|
PRIMARY | RxNorm | ||
|
DTXSID8052225
Created by
admin on Fri Dec 15 15:55:11 GMT 2023 , Edited by admin on Fri Dec 15 15:55:11 GMT 2023
|
PRIMARY | |||
|
DB13698
Created by
admin on Fri Dec 15 15:55:11 GMT 2023 , Edited by admin on Fri Dec 15 15:55:11 GMT 2023
|
PRIMARY | |||
|
458
Created by
admin on Fri Dec 15 15:55:11 GMT 2023 , Edited by admin on Fri Dec 15 15:55:11 GMT 2023
|
PRIMARY | |||
|
CHEMBL3707336
Created by
admin on Fri Dec 15 15:55:11 GMT 2023 , Edited by admin on Fri Dec 15 15:55:11 GMT 2023
|
PRIMARY | |||
|
Iron(II) carbonate
Created by
admin on Fri Dec 15 15:55:11 GMT 2023 , Edited by admin on Fri Dec 15 15:55:11 GMT 2023
|
PRIMARY | |||
|
4542
Created by
admin on Fri Dec 15 15:55:11 GMT 2023 , Edited by admin on Fri Dec 15 15:55:11 GMT 2023
|
PRIMARY | |||
|
C45678
Created by
admin on Fri Dec 15 15:55:11 GMT 2023 , Edited by admin on Fri Dec 15 15:55:11 GMT 2023
|
CONCEPT | Industrial Aid |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |